{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:32:46Z","timestamp":1778236366038,"version":"3.51.4"},"reference-count":47,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2008,11,14]],"date-time":"2008-11-14T00:00:00Z","timestamp":1226620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:p>Abstract<\/jats:p>\n                  <jats:p>Aripiprazole has recently received approval for the treatment of moderate to severe manic episodes in bipolar I disorder and prevention of new manic episodes in aripiprazole-responsive patients. Aripiprazole differs from other antipsychotics in its pharmacology, and the need for prescribing guidance in the UK was recently identified. A UK multidisciplinary panel was convened in November 2007. This report describes the consensus agreed during the meeting on the optimal approach to prescribing aripiprazole: how best to approach initiation of, and switching to, treatment with aripiprazole and management strategies for side effects. A literature review of the randomised controlled clinical trials of aripiprazole in mania supports these recommendations. Aripiprazole should be initiated at 15 mg\/day (range 5\u201320 mg\/day). If necessary, adjunctive medication should be used in early treatment to manage side effects or assist in management of symptoms such as agitation. When switching to aripiprazole, the therapeutic dose of current treatment should be maintained while adding aripiprazole 15 (5\u201320) mg\/day. Only once an effective dose of aripiprazole is reached should previous medication be reduced. Nausea, insomnia and agitation typically resolve within days. Some principles for dosing and switching are provided to assist with a successful treatment outcome with aripiprazole in mania.<\/jats:p>","DOI":"10.1177\/0269881108098820","type":"journal-article","created":{"date-parts":[[2008,11,14]],"date-time":"2008-11-14T20:34:19Z","timestamp":1226694859000},"page":"231-240","source":"Crossref","is-referenced-by-count":19,"title":["A UK consensus on the administration of aripiprazole for the treatment of mania"],"prefix":"10.1177","volume":"23","author":[{"given":"KJ","family":"Aitchison","sequence":"first","affiliation":[{"name":"MRC Social, Genetic and Development Psychiatry Centre (MRC), Institute of Psychiatry at King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bienroth","sequence":"additional","affiliation":[{"name":"Stepping Stones CMHT, OXLEAS NHS Foundation Trust, Bromley, Kent, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Cookson","sequence":"additional","affiliation":[{"name":"Royal London Hospital, Mile End Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Gray","sequence":"additional","affiliation":[{"name":"Faculty of Health, University of East Anglia, Norwich, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PM","family":"Haddad","sequence":"additional","affiliation":[{"name":"Greater Manchester West Mental Health NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Moore","sequence":"additional","affiliation":[{"name":"Hollins Park Hospital, 5 Boroughs Partnership NHS Trust, Warrington, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Ratna","sequence":"additional","affiliation":[{"name":"Barnet Psychiatric Unit, The Burroughs, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Sullivan","sequence":"additional","affiliation":[{"name":"School of Care Sciences, University of Glamorgan, Pontypridd, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Taylor","sequence":"additional","affiliation":[{"name":"Maudsley Hospital, South London and Maudsley NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Taylor","sequence":"additional","affiliation":[{"name":"Springpark Centre, Greater Glasgow and Clyde Primary Care Division, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GM","family":"Goodwin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2008,11,14]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200011000-00004"},{"key":"atypb2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00131746-200511001-00002","volume":"11","author":"Allen MH","year":"2005","journal-title":"J Psychiatr Pract"},{"key":"atypb3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.ajp.161.1.1","volume":"161","author":"APA","year":"2004","journal-title":"Am J Psychiatry"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(04)80353-5"},{"key":"atypb5","author":"Boulton DW","year":"2008","journal-title":"Psychopharmacol"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0116"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0613"},{"key":"atypb8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4088\/JCP.0207e05","volume":"68","author":"Buckley PF","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004269870"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90066-5"},{"key":"atypb11","volume-title":"Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression.","author":"Goodwin FK","year":"2007"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103017002003"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200721110-00004"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/10.3.388"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.6.1057"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1651"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.741"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0414"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1003"},{"key":"atypb20","doi-asserted-by":"crossref","unstructured":"Keck PE\u2004 Orsulak PJ\u2004 Cutler AJ\u2004 Sanchez R\u2004 Torbeyns A\u2004 Marcus RN\u2004 (2008) Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. Journal of Affective Disorders: In press.","DOI":"10.1016\/j.jad.2008.05.014"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.3.229"},{"key":"atypb22","unstructured":"Kornhauser D\u2004 Boulton D\u2004 Mallikaarjun S\u2004 Geraldes M\u2004 Dressler D\u2004 Carson W\u2004 (2005) Effects of aripiprazole on pharmacokinetics of lithium in healthy subjects. Presented at the American Psychiatric Association 158th Annual Meeting, Atlanta, GA, USA, May 21\u201326."},{"key":"atypb23","first-page":"56","volume":"63","author":"Maguire G","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.02.006"},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1080\/10401230590932380"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e3281938102"},{"key":"atypb27","doi-asserted-by":"crossref","unstructured":"Mir A; \u2004Shivakumar K; \u2004Williamson RJ; \u2004McAllister V; \u2004O'Keane V; \u2004Aitchison KJ; \u2004 (2008) Change in sexual dysfunction with aripiprazole: a switching or add-on study. J Psychopharmacol 22: 323\u2013329.","DOI":"10.1177\/0269881107082901"},{"key":"atypb28","unstructured":"Moore BJ; \u2004 (2004) Atypicals versus conventional treatment for bipolar disorder. Hospital Doctor, Psychiatry Supplement, December 2, 10\u201311."},{"key":"atypb29","volume-title":"National Collaborating Centre for Mental Health","year":"2006"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519001-00001"},{"key":"atypb31","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108091069"},{"key":"atypb32","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000169068.34322.70"},{"key":"atypb33","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106059693"},{"key":"atypb34","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2007.01.003"},{"key":"atypb35","unstructured":"Schieber F\u2004 Boulton D\u2004 Balch A\u2004 Croop R\u2004 Mallikaarjun S\u2004 Benson J\u2004 (2007) A non-randomized study to investigate the effects of aripiprazole on the steady-state pharmacokinetics of lamotrigine in subjects with bipolar I disorder. Poster presented at ASHP 2007."},{"key":"atypb36","doi-asserted-by":"publisher","DOI":"10.1177\/070674370104600407"},{"key":"atypb37","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2004.06.003"},{"key":"atypb39","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X210633"},{"key":"atypb40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2007.08.015"},{"key":"atypb41","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0704"},{"key":"atypb42","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.9.841"},{"key":"atypb43","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","volume":"156","author":"Tohen M","year":"1999","journal-title":"Am J Psychiatry"},{"key":"atypb44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2004.00155.x"},{"key":"atypb45","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.3.235"},{"key":"atypb46","doi-asserted-by":"crossref","unstructured":"Vieta E\u2004 T\u2019joen C\u2004 McQuade RD\u2004 Carson WH\u2004 Marcus RN\u2004 Sanchez R\u2004 (2008) Adjunctive aripiprazole in bipolar mania partially non-responsive to valproate\/lithium: a placebo-controlled study (CN138-134). American Journal of Psychiatry: Published online April 1; doi:10.1176\/appi.ajp.2008.07101560","DOI":"10.1176\/appi.ajp.2008.07101560"},{"key":"atypb47","author":"Young A","year":"2008","journal-title":"British Journal of Psychiatry"},{"key":"atypb48","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b13e318033bd5e"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881108098820","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881108098820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:11:19Z","timestamp":1777507879000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881108098820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,14]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1177\/0269881108098820"],"URL":"https:\/\/doi.org\/10.1177\/0269881108098820","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,14]]}}}